You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ixazomib (MLN9708)

Showing 1 - 25 of 130
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • High Risk Smoldering Multiple Myeloma
  • Basking Ridge, New Jersey
  • +5 more
Nov 15, 2022

Kaposi Sarcoma, Skin Trial in Los Angeles, Saint Louis (Ixazomib Citrate, Quality-of-Life Assessment, Questionnaire

Suspended
  • Kaposi Sarcoma
  • Skin
  • Ixazomib Citrate
  • +2 more
  • San Diego, California
  • +1 more
Jan 30, 2023

Glioblastoma Trial in Atlanta (Ixazomib)

Completed
Has Results
  • Glioblastoma
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Mar 2, 2021

Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 12, 2022

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
Jan 6, 2023

Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

Active, not recruiting
Has Results
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Mar 28, 2022

Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Active, not recruiting
  • Plasma Cell Myeloma
  • Daratumumab
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

Recruiting
  • Recurrent AL Amyloidosis
  • Refractory AL Amyloidosis
  • Biospecimen Collection
  • +9 more
  • Duarte, California
  • +10 more
Jan 19, 2023

Plasmacytoma, POEMS Syndrome Trial in Rochester (Dexamethasone, Ixazomib Citrate, Lenalidomide)

Active, not recruiting
  • Plasmacytoma
  • POEMS Syndrome
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 26, 2022

Recurrent Plasma Cell Myeloma Trial in Rochester (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 19, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Abatacept
  • +3 more
  • Buffalo, New York
  • +2 more
Dec 22, 2022

Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Residual Disease
  • Ixazomib Citrate
  • +2 more
  • Chicago, Illinois
    University of Chicago
Oct 5, 2021

Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston

Active, not recruiting
  • Metastatic Urothelial Carcinoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

Active, not recruiting
Has Results
  • Plasma Cell Leukemia
  • +2 more
  • Rochester, Minnesota
  • +1 more
May 19, 2022

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Duarte, California
  • +9 more
Jan 11, 2023

Multiple Myeloma Trial in Milwaukee (MLN9708, Dexamethasone, Bendamustine (multiple dose levels))

Completed
Has Results
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Sep 30, 2020

Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Atlanta, Georgia
  • +1 more
Oct 26, 2021

Myeloma Trial in La Jolla, Orange, Sacramento (Clarithromycin, Dexamethasone, Ixazomib Citrate)

Active, not recruiting
  • Myeloma
  • La Jolla, California
  • +2 more
Mar 14, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Canada, United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Little Rock, Arkansas
  • +23 more
Feb 24, 2022

Triple-Negative Breast Cancer Trial in Austria (Ixazomib, Carboplatin)

Terminated
  • Triple-Negative Breast Cancer
  • Wels, Oberösterreich, Austria
  • +11 more
Nov 26, 2020

Multiple Myeloma Trial in Little Rock (Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Science
May 17, 2021

Myeloid Hematologic Malignancy, Lymphoid Hematologic Malignancy Trial in New York (Ixazomib)

Completed
  • Myeloid Hematologic Malignancy
  • Lymphoid Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 3, 2021

Allogeneic Hematopoietic Stem Cell Transplantation Trial in Milwaukee (MLN9708)

Completed
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Nov 1, 2020